Cornerstone Sues Exela Over Generic Hypertension Drug
Cornerstone Therapeutics Inc. on Wednesday told a Delaware federal judge that Exela Pharma Sciences LLC infringed two of its patents when it asked the FDA to approve a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article